The maker of a little red pill intended to treat a rare condition is raking in hundreds of millions of dollars a year as it aggressively targets frail and elderly nursing home residents for whom the drug may be unnecessary…
By Blake Ellis and Melanie Hicken; Data analysis by Sergio Hernandez, CNN Investigates, The Southern: Living
Thu, 10/12/2017 - 6:32am
The maker of a little red pill intended to treat a rare condition is raking in hundreds of millions of dollars a year as it aggressively targets frail and elderly nursing home residents for whom the drug may be unnecessary…